Related Experiment Video
Updated: Jun 5, 2026

Human Pseudoislet System for Synchronous Assessment of Fluorescent Biosensor Dynamics and Hormone Secretory Profiles
Published on: November 3, 2023
Per-arnt-sim (PAS) domain-containing protein kinase is downregulated in human islets in type 2 diabetes and regulates
G da Silva Xavier1, H Farhan, H Kim
1Section of Cell Biology, Division of Diabetes, Endocrinology and Metabolism, Department of Medicine, Imperial College London, Exhibition Road, South Kensington, London SW7 2AZ, UK. g.dasilva-xavier@imperial.ac.uk
Aims/Hypothesis:
We assessed whether per-arnt-sim (PAS) domain-containing protein kinase (PASK) is involved in the regulation of glucagon secretion.
Methods:
mRNA levels were measured in islets by quantitative PCR and in pancreatic beta cells obtained by laser capture microdissection. Glucose tolerance, plasma hormone levels and islet hormone secretion were analysed in C57BL/6 Pask homozygote knockout mice (Pask-/-) and control littermates. Alpha-TC1-9 cells, human islets or cultured E13.5 rat pancreatic epithelia were transduced with anti-Pask or control small interfering RNAs, or with adenoviruses encoding enhanced green fluorescent protein or PASK.
Results:
PASK expression was significantly lower in islets from human type 2 diabetic than control participants. PASK mRNA was present in alpha and beta cells from mouse islets. In Pask-/- mice, fasted blood glucose and plasma glucagon levels were 25 ± 5% and 50 ± 8% (mean ± SE) higher, respectively, than in control mice. At inhibitory glucose concentrations (10 mmol/l), islets from Pask-/- mice secreted 2.04 ± 0.2-fold (p < 0.01) more glucagon and 2.63 ± 0.3-fold (p < 0.01) less insulin than wild-type islets. Glucose failed to inhibit glucagon secretion from PASK-depleted alpha-TC1-9 cells, whereas PASK overexpression inhibited glucagon secretion from these cells and human islets. Extracellular insulin (20 nmol/l) inhibited glucagon secretion from control and PASK-deficient alpha-TC1-9 cells. PASK-depleted alpha-TC1-9 cells and pancreatic embryonic explants displayed increased expression of the preproglucagon (Gcg) and AMP-activated protein kinase (AMPK)-alpha2 (Prkaa2) genes, implying a possible role for AMPK-alpha2 downstream of PASK in the control of glucagon gene expression and release.
Conclusions/Interpretation:
PASK is involved in the regulation of glucagon secretion by glucose and may be a useful target for the treatment of type 2 diabetes.
Insights
Per-arnt-sim (PAS) domain-containing protein kinase (PASK) regulates glucagon secretion. Lower PASK levels in type 2 diabetes suggest PASK as a potential therapeutic target.
Area of Science:
- Endocrinology
- Molecular Biology
- Metabolic Diseases
Background:
- Glucagon is a key hormone regulating blood glucose levels.
- Dysregulation of glucagon secretion is implicated in type 2 diabetes.
- The role of per-arnt-sim (PAS) domain-containing protein kinase (PASK) in glucagon regulation is not well understood.
Purpose of the Study:
- To investigate the involvement of PASK in the regulation of glucagon secretion.
- To explore the potential of PASK as a therapeutic target for type 2 diabetes.
Main Methods:
- Quantitative PCR to measure PASK mRNA levels in human islets and mouse pancreatic cells.
- Analysis of glucose tolerance, plasma hormone levels, and islet hormone secretion in Pask knockout mice.
- In vitro studies using alpha-TC1-9 cells and human islets with PASK knockdown or overexpression.
Main Results:
- PASK expression was reduced in islets from human type 2 diabetic patients.
- Pask knockout mice exhibited elevated fasting blood glucose and plasma glucagon levels.
- PASK depletion impaired glucose-inhibited glucagon secretion and affected insulin secretion.
- PASK overexpression inhibited glucagon secretion, suggesting a role in its regulation.
Conclusions:
- PASK plays a significant role in glucose-mediated regulation of glucagon secretion.
- PASK may serve as a potential therapeutic target for managing type 2 diabetes.
Related Concept Videos
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Insulin: The Receptor and Signaling Pathways
The JAK-STAT Signaling Pathway
Cell Specific Gene Expression
cAMP-dependent Protein Kinase Pathways
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...

